http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
이연구(Y G Lee),노준규(J K Loh),이창걸(C G Lee),이종영(J Y Lee),김귀언(G E Kim),서창옥(C O Suh),홍원표(W P Houng) 대한두경부종양학회 1988 대한두경부 종양학회지 Vol.4 No.1
Radiation therapy is generally considered to be the treatment of choice in T₁ glottic cancer, maninly because of preservation of voice function and its local control rate is comparable to that of surgery. Failures from radiation therapy can be ultimately salvaged by surgery. A retrospective analysis of the treatment of 25 patients with T₁ glottic cancer seen at the Y onsei Cancer Center from 1980 to 1984 is presented. Radiation dose to the target volume varied from 6400 to 7000 cGy in 6-7 weeks. The local control rate is 84%. Four patients had primary failure and three of these patients had salvage surgery. Of the 3 patients who had salvage surgery, 2 were cured and aonther one was died with progression of the disease. 5-year acturial and disease free survival rate are 91.1%, 78.0% respectively.
박경란(K R Park),이창걸(C G Lee),김수곤(S K Kim),조관호(K H Cho),서창옥(C O Suh),김귀언(G E Kim),노준규(J K Loh),김병수(B S Kim)홍원표(W P Hong),박정수(C S Park) 대한두경부종양학회 1987 대한두경부 종양학회지 Vol.3 No.1
Clinical application of hyperthermia using 8 MHz radiofrequency (capacitive type THER-MOTRON RF-8) in cancer treatment was begun at Yonsei Cancer Center in 19&5. From April 1985 to April 1986, 23 patients with loco-regionally advanced and persistent or recurrent carcinomas of the head and neck were treated with hyperthermia at the Department of Radiation Oncology, Yonsei University College of Medicine. Radiation therapy and/orchemotherapy were combined with hyperthermia to improve the tumor response. The response rate of 23 patients was 52%, 4 had complete response, and 7 had partial response. The factors affecting the tumor response were dose of irradiation (P= 0.009). Complications related to treatment were found in 8 patients and all of them were self-limited. The result of this study indicates that localized hyperthermia as a combined modality has a significant role in palliation of advanced and recurrent head and neck cancer.
고은희(E H Koh),노준규(J K Loh),김귀언(G E Kim),서창옥(C O Suh),김수곤(S K Kim),김병수(B S Kim),홍원표(W P Hong),박경란(K R Park),이창걸(C G Lee) 대한두경부종양학회 1987 대한두경부 종양학회지 Vol.3 No.1
Chondrosarcoma of the head and neck is very rare tumor and this incidence was reported to be about 10% of all chondrosarcomas. Maxilla is the most common site of involvement and mandible, paransal sinus, nasal cavity and base of skull in that order. In general, chondrosarcoma has been known to be radioresistant, however since the Princess Margaret Hospital reported that it was radioresponsive tumor in 1980, the role of radiotherapy has been emphasized in terms of local control, especially in head and neck regions where complete excion is often difficult to achieve. The authors experienced 4 cases of chondrosarcoma of head and neck among all 29 chondrosarcoma patients from 1971 to 1985. The clinical and pathologic feature of this disease, it's treatment and prognosis were reviewed along with the literatures.